The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...

Building on its reputation for fostering breakthrough approaches to precision medicine, the 24th annual Bio-IT World Conference & Expo, April 2-4 in Boston, will feature a plenary keynote program of ...

Head and neck oncology is a multifaceted field that integrates the expertise of various specialists including otorhinolaryngologists, oncologists, ...

Like Rigetti, Palantir's stock skyrocketed during the past year, with its share price up 226% through the week ended March 7.

Despite wartime challenges, Ukrainians remain resilient in their spending habits, shifting from frequent purchases to higher ...

In this rapidly growing digital era, healthcare is witnessing an unprecedented transformation through artificial intelligence ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a ...

Tragic incidents like Sewell’s highlight the urgency of understanding generative AI technologies (GenAI) and their impact on ...

AI for a task that should be done by a physician rather than using it for other burdens that are less worthy than expressing care for patients,” authors of an editorial wrote.

Alongside new steps in its therapeutic pipeline—and a new push into laboratory robotics—Insilico Medicine has raised $110 ...

This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health and medicine.